$365 Million is the total value of Alphabet Inc.'s 4 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ARRS | New | Arris Group Inc New | $259,550,000 | – | 10,663,500 | +100.0% | 71.10% | – |
FMI | New | Foundation Medicine Inc | $58,232,000 | – | 2,444,652 | +100.0% | 15.95% | – |
SALE | New | RetailMeNot Inc | $45,889,000 | – | 1,593,936 | +100.0% | 12.57% | – |
FB | New | Facebook Inccl a | $1,379,000 | – | 25,231 | +100.0% | 0.38% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
DEXCOM INC | 20 | Q3 2023 | 17.4% |
Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
ALECTOR INC | 19 | Q3 2023 | 1.1% |
Lyft Inc | 18 | Q2 2023 | 51.9% |
QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
8-K | 2024-06-13 |
144 | 2024-06-12 |
4 | 2024-06-12 |
8-K | 2024-06-07 |
144 | 2024-06-05 |
144 | 2024-06-05 |
4 | 2024-06-05 |
8-K | 2024-06-05 |
4 | 2024-06-03 |
4 | 2024-06-03 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.